Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11159021rdf:typepubmed:Citationlld:pubmed
pubmed-article:11159021lifeskim:mentionsumls-concept:C1516511lld:lifeskim
pubmed-article:11159021lifeskim:mentionsumls-concept:C0086860lld:lifeskim
pubmed-article:11159021lifeskim:mentionsumls-concept:C1518425lld:lifeskim
pubmed-article:11159021lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:11159021lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:11159021lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:11159021lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:11159021pubmed:issue3lld:pubmed
pubmed-article:11159021pubmed:dateCreated2001-2-22lld:pubmed
pubmed-article:11159021pubmed:abstractTextTranscription of the human inducible nitric oxide synthase (iNOS) gene is regulated by inflammatory cytokines in a tissue-specific manner. To determine whether differences in cytokine-induced mRNA levels between pulmonary epithelial cells (A549) and hepatic biliary epithelial cells (AKN-1) result from different protein or DNA regulatory mechanisms, we identified cytokine-induced changes in DNase I-hypersensitive (HS) sites in 13 kb of the iNOS 5'-flanking region. Data showed both constitutive and inducible HS sites in an overlapping yet cell type-specific pattern. Using in vivo footprinting and ligation-mediated PCR to detect potential DNA or protein interactions, we examined one promoter region near -5 kb containing both constitutive and cytokine-induced HS sites. In both cell types, three in vivo footprints were present in both control and cytokine-treated cells, and each mapped within a constitutive HS site. The remaining footprint appeared only in response to cytokine treatment and mapped to an inducible HS site. These studies, performed on chromatin in situ, identify a portion of the molecular mechanisms regulating transcription of the human iNOS gene in both lung- and liver-derived epithelial cells.lld:pubmed
pubmed-article:11159021pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11159021pubmed:languageenglld:pubmed
pubmed-article:11159021pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11159021pubmed:citationSubsetIMlld:pubmed
pubmed-article:11159021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11159021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11159021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11159021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11159021pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11159021pubmed:statusMEDLINElld:pubmed
pubmed-article:11159021pubmed:monthMarlld:pubmed
pubmed-article:11159021pubmed:issn1040-0605lld:pubmed
pubmed-article:11159021pubmed:authorpubmed-author:WatersM FMFlld:pubmed
pubmed-article:11159021pubmed:authorpubmed-author:ChesrownS ESElld:pubmed
pubmed-article:11159021pubmed:authorpubmed-author:BilliarT RTRlld:pubmed
pubmed-article:11159021pubmed:authorpubmed-author:NickH SHSlld:pubmed
pubmed-article:11159021pubmed:authorpubmed-author:GellerD ADAlld:pubmed
pubmed-article:11159021pubmed:authorpubmed-author:MellottJ KJKlld:pubmed
pubmed-article:11159021pubmed:issnTypePrintlld:pubmed
pubmed-article:11159021pubmed:volume280lld:pubmed
pubmed-article:11159021pubmed:ownerNLMlld:pubmed
pubmed-article:11159021pubmed:authorsCompleteYlld:pubmed
pubmed-article:11159021pubmed:paginationL390-9lld:pubmed
pubmed-article:11159021pubmed:dateRevised2011-10-27lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:meshHeadingpubmed-meshheading:11159021...lld:pubmed
pubmed-article:11159021pubmed:year2001lld:pubmed
pubmed-article:11159021pubmed:articleTitleCytokine-induced changes in chromatin structure and in vivo footprints in the inducible NOS promoter.lld:pubmed
pubmed-article:11159021pubmed:affiliationDepartment of Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida 32610, USA.lld:pubmed
pubmed-article:11159021pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11159021pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11159021lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11159021lld:pubmed